Curr Opin Otolaryngol Head Neck Surg. 2025 Apr 3. doi: 10.1097/MOO.0000000000001048. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: This is a comprehensive overview of current trends in the prevalence, clinical presentation, diagnostic challenges and management of granulomatous disorders involving
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Nov 28;49(11):1821-1827. doi: 10.11817/j.issn.1672-7347.2024.240375.ABSTRACTOBJECTIVES: Diabetes mellitus is closely associated with sudden sensorineural hearing loss (SSNHL), but no definitive evidence has established a causal relationship between type 1 di
Acta Pharm Sin B. 2025 Feb;15(2):892-908. doi: 10.1016/j.apsb.2024.11.022. Epub 2024 Dec 2.ABSTRACTStearoyl-coenzyme A desaturase 1 (SCD1) catalyzes the rate-limiting step of de novo lipogenesis and modulates lipid homeostasis. Although numerous SCD1 inhibitors were tested for treating metabolic dis
Front Med (Lausanne). 2025 Mar 19;12:1505530. doi: 10.3389/fmed.2025.1505530. eCollection 2025.ABSTRACTBACKGROUND: Macular edema (ME) is an ophthalmic disease that poses a serious threat to human vision. Anti-vascular endothelial growth factor (anti-VEGF) therapy has become the first-line treatment
Clin Rev Allergy Immunol. 2025 Apr 2;68(1):36. doi: 10.1007/s12016-025-09049-y.ABSTRACTCongenital heart defects (CHD) are the most common major birth defects and one of the leading causes of death from congenital defects after birth. CHD can arise in pregnancy from the combination of genetic and non
Soc Sci Med. 2025 Feb 6;373:117819. doi: 10.1016/j.socscimed.2025.117819. Online ahead of print.ABSTRACTRegular follow-up visits are a crucial component of prevention and care for several important non-communicable diseases (NCDs). Yet evidence across low- and middle-income countries (LMICs) reveals
Mol Nutr Food Res. 2025 Apr 2:e202400523. doi: 10.1002/mnfr.202400523. Online ahead of print.ABSTRACTThe Myrica rubra pomace polyphenols (MRPP) were used to study their hypoglycemic effects and mechanisms using Type 2 diabetes (T2D) (db/db) mice as the model. The results showed that the oral adminis
No abstractLancet Reg Health West Pac. 2025 Mar 17;56:101505. doi: 10.1016/j.lanwpc.2025.101505. eCollection 2025 Mar.NO ABSTRACTPMID:40171472 | PMC:PMC11960639 | DOI:10.1016/j.lanwpc.2025.101505
Scand J Immunol. 2025 Apr;101(4):e70020. doi: 10.1111/sji.70020.ABSTRACTCardiovascular diseases (CVDs) remain a leading cause of global mortality, driven by risk factors such as dyslipidemia, hypertension and diabetes. Recent research has highlighted the critical role of inflammasomes, particularly
Nat Commun. 2025 Apr 1;16(1):3124. doi: 10.1038/s41467-025-58278-4.ABSTRACTHypoglycemia is a serious and potentially life-threatening condition for people with insulin-dependent diabetes. To provide a safeguard against hypoglycemia, we introduce a "smart" microneedle (MN) patch that senses glucose l
No abstractJ Nephrol. 2025 Apr 1. doi: 10.1007/s40620-025-02240-6. Online ahead of print.NO ABSTRACTPMID:40169472 | DOI:10.1007/s40620-025-02240-6
No abstractDiabetes Res Clin Pract. 2025 Mar 30:112157. doi: 10.1016/j.diabres.2025.112157. Online ahead of print.NO ABSTRACTPMID:40169088 | DOI:10.1016/j.diabres.2025.112157
Crit Rev Anal Chem. 2025 Apr 1:1-22. doi: 10.1080/10408347.2025.2486211. Online ahead of print.ABSTRACTInsulinotropic agents are a common class of antihyperglycemic drugs. Insulinotropic agents mainly include glinides and sulfonylureas. Because it can reduce postprandial blood glucose in patients wi
Eur J Nutr. 2025 Apr 1;64(3):143. doi: 10.1007/s00394-025-03655-4.ABSTRACTPURPOSE: Postprandial glycaemic control is critical for diabetes prevention and management. Various dietary strategies have been explored to modulate postprandial glycaemia, with the inclusion of innovative fibres showing prom
Eur J Clin Pharmacol. 2025 Apr 1. doi: 10.1007/s00228-025-03830-w. Online ahead of print.ABSTRACTBACKGROUND: The renin-angiotensin-aldosterone system (RAAS) is a vital endocrine system that plays a crucial role in maintaining homeostasis. However, excessive activation of the RAAS can contribute to t
Clin Transl Sci. 2025 Apr;18(4):e70217. doi: 10.1111/cts.70217.ABSTRACTScientific advancements in pharmacology have revolutionized disease management, significantly enhancing global health. Innovations like biological therapies and mRNA vaccines underscore the field's capacity to address complex con
Diabetol Int. 2025 Jan 24;16(2):303-315. doi: 10.1007/s13340-025-00794-1. eCollection 2025 Apr.ABSTRACTSodium glucose cotransporter-2 (SGLT2) inhibitors improve glycemic control and reduce body weight (BW) in individuals with type 2 diabetes. However, there are still concerns that compensatory hyper
Front Immunol. 2025 Mar 17;16:1563450. doi: 10.3389/fimmu.2025.1563450. eCollection 2025.ABSTRACTAntimicrobial resistance (AMR) has become a major and escalating global health threat, undermining the effectiveness of current antibiotic and antimicrobial therapies. The rise of multidrug-resistant bac
Diabetes Metab Syndr Obes. 2025 Mar 27;18:905-916. doi: 10.2147/DMSO.S512089. eCollection 2025.ABSTRACTPURPOSE: Yuquan capsule (YQC) is a well-known proprietary Chinese medicine used for the treatment of type 2 diabetes mellitus. The aim of this study was to investigate the potential mechanism and e
BMC Endocr Disord. 2025 Mar 31;25(1):88. doi: 10.1186/s12902-025-01905-4.ABSTRACTBACKGROUND: Innovations in diabetes technology have consistently improved outcomes of persons with type1 diabetes (PWDs). However, the volumes of data that these technologies yield require different workflows to allevia
Ann Intern Med. 2025 Apr 1. doi: 10.7326/ANNALS-25-00990. Online ahead of print.ABSTRACTDuring 2024, there were many practice-changing innovations in the field of endocrinology, particularly related to the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs). From the substantial new evidence
N Engl J Med. 2025 Mar 30. doi: 10.1056/NEJMoa2415879. Online ahead of print.ABSTRACTBACKGROUND: Five risk factors account for approximately 50% of the global burden of cardiovascular disease. How the presence or absence of classic risk factors affects lifetime estimates of cardiovascular disease an
J Clin Tuberc Other Mycobact Dis. 2025 Mar 5;39:100515. doi: 10.1016/j.jctube.2025.100515. eCollection 2025 May.ABSTRACTBACKGROUND: Drug-resistant tuberculosis poses a major global public health threat, with adverse drug reactions complicating treatment and contributing to mortality. In Ethiopia, al
Obes Sci Pract. 2025 Mar 28;11(2):e70049. doi: 10.1002/osp4.70049. eCollection 2025 Apr.ABSTRACTBACKGROUND: Residential programs have been utilized for the treatment of adolescents with severe obesity, yet few have been evaluated.OBJECTIVE: The objectives were to (1) evaluate the effect of a long-te
